AAAAAA

   
Results: 1-15 |
Results: 15
A CLINICAL-EVALUATION OF RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA - A 10-WEEK, OPEN-LABEL, MULTICENTER TRIAL
Authors: JESTE DV KLAUSNER M BRECHER M CLYDE C JONES R ABUZZAHAB FS AHMAD A AHMED S AINSLIE G ALIDON G JAMPALA VC ANDRIULLI G ASHLEIGH EA AUKSTUOLIS J BACON RJ BADHIWALA SP BAGRI KS BALDWIN JD BARDINELLI AJ BARON D BARTHOLOW G BEACH RL BERA RB BERKEY R BIRD LJ BOYER W ESCALONA R CACCIOPPOLI G TALIAFERRO J CARTER RG CENTRIC RW CHARALAMPOUS KD CHASTEK JW CHAUHAN N CHO SN COHEN AJ COHN CK CORDER SL CUERVO MS CUTLER MO DAMERA BR HAMILTON RS DANIELS K DASKALOV Z DAVID A DAVIS H DELEON J DELLARIO AV DIRKSEN JS DOSSANTOS E DOW TW DOWNIE D DRELL WK EKHOLM C ELIO E FABRE L FALCI T FISHBEIN JH FREER JH FRENKEL D FULLER W GERHARDSTEIN R GRACE J GREINER T GUPTA BK HAMADANI HG HARTFORD JT HEGE DL HICKS PB HILL WJ HOLINER J HOLLAND PJ HORNE RL IBE IO ISHAQUE S IVORY PB JACOBSON C JAMIESON RC JOHNSON CG KENNEDY B KESKINER A KLING A KLUGHEIT M KOHLI AK KOMARLA AK LANIER P LEONE NF LILES JR LU TC MAHFOOZI H MALEKPOUR B MALONE DA MANNAVA P MANNING DB MANSCHRECK T MCLARNON MC MCMINN MR MEELEE D MEGOWEN GL MEHLER C MERAYO HE MIAN MA MINGIONE DL MITTAL D MODIR K MOON TK MUNOZ RA NADEL SM NAGI K NALLURI AC NOORDSIJ AJ ORELLANA E PASTERNAK IM PATEL D PATWA VK PETRIE WM PINSKI G PUESAN R QADRI MK RAFULS WA RAICHMAN JA RAMESHWAR ER RAO TV REBECK B STUMPF A REIST C RHEW SS RISBY ED ROCK NL ROSENBLATT S ROSENSTOCK HA ROSILLO R ROSSON BA ROY SK RUIZ EG SANCLEMENTE JP SANDERS RQ SANDLER NH SCHLUETER J SCHOOFF K SHINDERMAN M SOLOMON R SPIVY DF STEPHENS W SWE NN THOMPSON PM THORNELOE WF TIRANDAZ H TUAN CH TUCKER TA UNFRIED GJ VALKO TR VEITS H VILLALBA AE VOLLMER S WALKER P WANG GL WEAVER KE WEICHBRODT G WEISE CC WEISS KJ WELLSHEAR CC YAPALATER AR YERASI B YOUNG AS ZAKALA M ZOBER JM ZUKOF D
Citation: Dv. Jeste et al., A CLINICAL-EVALUATION OF RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA - A 10-WEEK, OPEN-LABEL, MULTICENTER TRIAL, Psychopharmacology, 131(3), 1997, pp. 239-247
EVALUATION OF INDAPAMIDE 1.25 MG ONCE-DAILY IN ELDERLY PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: FIDDES R BLUMENTHAL J DAWSON JE DYCKMAN E HAMMOND PGSJ HARRIS S LASSETER KC LEVINE BS MONTORO R NIEDERMAN AL RATNER PH ROSENBLATT S TOTH PD VERGIS J CODISPOTI J
Citation: R. Fiddes et al., EVALUATION OF INDAPAMIDE 1.25 MG ONCE-DAILY IN ELDERLY PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 11(4), 1997, pp. 239-244
DIFFERENTIAL MODULATION OF CELL-ADHESION BY INTERACTION BETWEEN ADHESIVE AND COUNTER-ADHESIVE PROTEINS - CHARACTERIZATION OF THE BINDING OFVITRONECTIN TO OSTEONECTIN (BM40, SPARC)
Authors: ROSENBLATT S BASSUK JA ALPERS CE SAGE EH TIMPL R PREISSNER KT
Citation: S. Rosenblatt et al., DIFFERENTIAL MODULATION OF CELL-ADHESION BY INTERACTION BETWEEN ADHESIVE AND COUNTER-ADHESIVE PROTEINS - CHARACTERIZATION OF THE BINDING OFVITRONECTIN TO OSTEONECTIN (BM40, SPARC), Biochemical journal, 324, 1997, pp. 311-319
IDENTIFICATION OF NOVEL HEPARIN-BINDING DOMAINS OF VITRONECTIN
Authors: LIANG OD ROSENBLATT S CHHATWAL GS PREISSNER KT
Citation: Od. Liang et al., IDENTIFICATION OF NOVEL HEPARIN-BINDING DOMAINS OF VITRONECTIN, FEBS letters, 407(2), 1997, pp. 169-172
REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA AND FREQUENCY OF HYPOGLYCEMIAIN IDDM PATIENTS ON INSULIN-ANALOG TREATMENT
Authors: ANDERSON JH BRUNELLE RL KOIVISTO VA PFUTZNER A TRAUTMANN ME VIGNATI L DIMARCHI R BOWEN KM CAMERON DP NANKERVIS AJ ROBERTS AP ZIMMET P BORKENSTEIN MH SCHERNTHANER G WALDHAUSL WK DELEEUW IH FERY F SCHEEN A SOMERS G FETTES IM TILDESLEY HD TOTH EL VIIKARI J ALTMAN JJ BOUGNERES PF DROUIN P FOSSATI P GUILLAUSSEAU PJ MARECHAUD E RIOU JP SELAM JL VIALETTES PB BEYER J FEDERLIN K FUSSGANGER RD GRIES FA JASTRAM HU KOOP I LANDGRAF R ROSAK C SCHATZ H SCHULZESCHLEPPINGHOFF B SEIF FJ STOECKMANN F KARASIK A WEITZMAN S ANDREANI D BOMPIANI G CREPALDI G GIORGINO R GRECO AV LAURO R MAINGAY D MANCINI M MENZINGER G MUGGEO M PAGANO G SACCA L TIENGO A VIGNERI R ERKELENS DW JANSSENS EN LEKKERKERKER JF SPIJKER AJ DANIELS AR FOLLING I BONNICI FB MOLLENTZE WF MOORE R OMAR MA ROBERTSON LI ASTORGA R DELEIVA A JARA A VAZQUEZ JA VILLARDELL E AGARDH CD ALEXANDER WD BARNETT AH CASSAR J HITMAN GA KESSON CM OHARE JP SHAW KM WALES JK ARSLANIAN S BASTYR EJ BLEVINS TC BOYCE PA BRINK SJ CLARKE DH DECLUE T GARBER AJ GUTHRIE RA JOHNSON DG KROSNICK A LINARELLI LG MCCULLOCH DK MEZITIS NH RASKIN P REEVES ML ROSENBLATT S SCHIMEL D SKYLER JS SONNENBERG GE WHITEHOUSE FW ZIMMERMAN B
Citation: Jh. Anderson et al., REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA AND FREQUENCY OF HYPOGLYCEMIAIN IDDM PATIENTS ON INSULIN-ANALOG TREATMENT, Diabetes, 46(2), 1997, pp. 265-270
TRANSURETHRAL ALPROSTADIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES - EFFECT OF DURATION OF DIABETES ON EFFICACY
Authors: KAISER FE BLOCK MB BOOKIN S DECHERNEY GS HERSHON KS NOLTEN WE NORWOOD PC ROSENBLATT S ROSENSTOCK J SCHALCH DS SCHWARTZ SL STEPHENS D TAM PY TODD LK GESUNDHEIT N
Citation: Fe. Kaiser et al., TRANSURETHRAL ALPROSTADIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES - EFFECT OF DURATION OF DIABETES ON EFFICACY, Diabetes, 46, 1997, pp. 637-637
RECURRENT DILATED CARDIOMYOPATHY REVERSED WITH CONVERSION OF ATRIAL-FIBRILLATION
Authors: KESSLER G ROSENBLATT S FRIEDMAN J KAPLINSKY E
Citation: G. Kessler et al., RECURRENT DILATED CARDIOMYOPATHY REVERSED WITH CONVERSION OF ATRIAL-FIBRILLATION, The American heart journal, 133(3), 1997, pp. 384-386
GLIMEPIRIDE, A NEW ONCE-DAILY SULFONYLUREA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF NIDDM PATIENTS
Authors: ROSENSTOCK J SAMOLS E MUCHMORE DB SCHNEIDER J ABELOVE WA ASPLIN CM BERGSTROM RW BERHANU P BOROWSKI GD BROWNING GV COMSTOCK JP FRIEDMAN NM GOLLAPUDI GM GRABER AL GUTHRIE RA HENSON BE HERSHON KS KROSNICK A LEVIN SR LEVY P LOCK JP LODEWICK PA MERSEY JH MICHIE DD MATHER SR MUSEY VC PALMER JP PETERS PJ POULOS JT PRENDERGAST JJ REYNOLDS LR ROBERTS VL ROSENBLATT S ROSENTHAL AR CAVANAUGH JJ SCHNEIDER SH SNYDER JW SWEET RA VESTAL RE
Citation: J. Rosenstock et al., GLIMEPIRIDE, A NEW ONCE-DAILY SULFONYLUREA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF NIDDM PATIENTS, Diabetes care, 19(11), 1996, pp. 1194-1199
CAPTOPRIL REDUCES THE RISK OF NEPHROPATHY IN IDDM PATIENTS WITH MICROALBUMINURIA
Authors: BONER G VANDYK DJ TAN MH TAN J EKSTRAND A KOIVISTO VA GROOP LC GROOP PH LUCAS A ROMERO R SALINAS I SANMARTI A ESCOBAR F ESCOBARJIMENEZ F CAMPOSPASTOR MM MUGOZ M GOMEZ M MANGILI R POZZA G SPOTTI D HANSEN KW CHRISTIANSEN JS KLEIN F MOGENSEN CE ZIEKENHUIS M VANDOORN LG SPOOREN PFMJ CRUICKSHANK JK JERVELL J PAUS PN BARNES DJ COLLINS A VIBERTI GC WILLIAMS G NELSTROP GA AMOROSA L ANOLIK JR ARONOFF SL EUBANK B BAILIE M PELLETIER L BLEVINS T CHARLES MA PERRY M CLARKE D TOMKEY D EINHORN D HUMPHRIES D GARBER AJ HAAG B WILLIAMS E HOY W WATKINS M KAHKONEN D KRUGER D KILO C LAFFEL L GOLDEN E LODEWICK P LOVINSKY D MASON J JOHNSON S MCGILL J SCHMIDT L ORLANDER P SORENSON K RASKIN P HELLENBRAND D ROSENBLATT S SCHWARTZ S AUFIERI J SHEEHAN JP ULCHAKER M SKYLER JS AGRAMONTE R STARR J GAGLIASTRE D TAYLOR T DAWN K WARD WK RIGDON M COOPER M GANS DJ
Citation: G. Boner et al., CAPTOPRIL REDUCES THE RISK OF NEPHROPATHY IN IDDM PATIENTS WITH MICROALBUMINURIA, Diabetologia, 39(5), 1996, pp. 587-593
MULTICENTER DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TRANSURETHRAL ALPROSTADIL IN DIABETIC AND NONDIABETIC MEN WITH CHRONIC ERECTILE DYSFUNCTION (IMPOTENCE)
Authors: NORWOOD PC BLOCK MB BOOKIN S DECHERNEY GS HEATLEY SA HERSHON KS KAISER FE ROSENBLATT S ROSENSTOCK J GESUNDHEIT N SPIVAK AP STEPHENS DE TAM PY PLACE VA
Citation: Pc. Norwood et al., MULTICENTER DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TRANSURETHRAL ALPROSTADIL IN DIABETIC AND NONDIABETIC MEN WITH CHRONIC ERECTILE DYSFUNCTION (IMPOTENCE), Diabetes, 45, 1996, pp. 716-716
MAGNESIUM FOR REDUCTION OF PULMONARY-ARTERY PRESSURE IN PRIMARY PULMONARY-HYPERTENSION
Authors: SHECHTER M ROSENBLATT S MOTRO M RABINOWITZ B KAPLINSKY E AGRANAT O
Citation: M. Shechter et al., MAGNESIUM FOR REDUCTION OF PULMONARY-ARTERY PRESSURE IN PRIMARY PULMONARY-HYPERTENSION, Magnesium-Bulletin, 17(4), 1995, pp. 115-117
BASIC FIBROBLAST GROWTH-FACTOR DILATES RAT PIAL ARTERIOLES
Authors: ROSENBLATT S IRIKURA K CADAY CG FINKLESTEIN SP MOSKOWITZ MA
Citation: S. Rosenblatt et al., BASIC FIBROBLAST GROWTH-FACTOR DILATES RAT PIAL ARTERIOLES, Journal of cerebral blood flow and metabolism, 14(1), 1994, pp. 70-74
3-YEAR SAFETY AND EFFICACY DATA ON THE USE OF FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Authors: STONER E ANDRIOLE GL BOAKE R BRACKEN BR BRANNAN W FUSELIER H BREMNER W BRUSKEWITZ RC COX CE PATTERSON AL CUNNINGHAM GR DEVINE PC SCHELLHAMMER PF ELHILALI M GELLER J GRAYHACK JT HARRISON LH HUDSON PB IMPERATO J VAUGHAN ED LIEBER MM LIPPERT MC MALEK GH MCCONNELL JD NARAYAN P PERREAULT JP RESNICK MI NORMAN R RITTMASTER R ROMAS NA ROSNER W ROSENBLATT S ROY JB SEIDMON EJ TENOVER JS TRACHTENBERG J WILLIAMS RD WALSH PC MOCELLINI A GARDINER R MARSHALL V JOHNSON W BARTSCH G SCHMIDBAUER CP MOSSIG H GASSER G VANCANGH PJ DENIS LJ ARAP S FREIRE GC DELATORRE D BOTTO H RICHARD F DEVONEC M TEILLAC P VALLANCIEN G BRAF Z DISILVERIO F MIANO L PAGANO F GABILONDO F DEBRUYNE F JANKNEGT RA SCHROEDER FH ROLLEMA HJ NACEY J FURTADO LA CARRETERO P JIMENEZ FC HAURI D OTTO R OTTO U ALBRECHT J ALTWEIN JE EGGHART G ENGELMANN U JACOBI GH KREYES G PANIJEL M RIEDASCH G RUGENDORFF EW WEIZERT P FABRICIUS P OBOYLE PJ GINGELL C HEAL MR CHARIG C
Citation: E. Stoner et al., 3-YEAR SAFETY AND EFFICACY DATA ON THE USE OF FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, Urology, 43(3), 1994, pp. 284-294
THE VALUE OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN EVALUATION OF PATIENTS AFTER THE FIRST UNCOMPLICATED ACUTE MYOCARDIAL-INFARCTION
Authors: BARASCH E ROSENBLATT S KAPLINKSY E VERED Z
Citation: E. Barasch et al., THE VALUE OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN EVALUATION OF PATIENTS AFTER THE FIRST UNCOMPLICATED ACUTE MYOCARDIAL-INFARCTION, Cardiology, 85(1), 1994, pp. 47-52
THE ROLE OF FIBRINOLYSIS IN THE CROSS-TALKS AMONG VESSEL WALL COMPONENTS - THE VITRONECTIN-PAI-1 AXIS
Authors: PREISSNER KT KOST C ROSENBLATT S DEBOER H HAMMES HP PANNEKOEK H
Citation: Kt. Preissner et al., THE ROLE OF FIBRINOLYSIS IN THE CROSS-TALKS AMONG VESSEL WALL COMPONENTS - THE VITRONECTIN-PAI-1 AXIS, Fibrinolysis, 7, 1993, pp. 18-19
Risultati: 1-15 |